Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-05 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.85 | 0.0002 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0006 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.005 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |